Review
Chemotherapy in the elderly: further considerations
Affiliations
- PMID: 20187326
Item in Clipboard
Review
Chemotherapy in the elderly: further considerations
Oncology (Williston Park).
2010 Jan.
Free article
No abstract available
Comment on
-
Cancer chemotherapy in the elderly patient.Oncology (Williston Park). 2010 Jan;24(1):76-85. Oncology (Williston Park). 2010. PMID: 20187325 Review.
Similar articles
-
Introduction and commentary: Paving the way for biosimilars in oncology.Semin Oncol. 2013 Dec;40 Suppl 1:S1-4. doi: 10.1053/j.seminoncol.2013.09.014. Epub 2013 Oct 4. Semin Oncol. 2013. PMID: 24267943 No abstract available.
-
Drugs are scarce as mix of programs aims to ease access.J Natl Cancer Inst. 2009 Oct 7;101(19):1304-6. doi: 10.1093/jnci/djp343. Epub 2009 Sep 15. J Natl Cancer Inst. 2009. PMID: 19755680 No abstract available.
-
Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.Oncologist. 2010;15 Suppl 1:49-57. doi: 10.1634/theoncologist.2010-S1-49. Oncologist. 2010. PMID: 20237218 No abstract available.
-
Cost of cancer clinical trials in elderly patients.Expert Opin Pharmacother. 2004 Mar;5(3):505-11. doi: 10.1517/14656566.5.3.505. Expert Opin Pharmacother. 2004. PMID: 15013919 Review.
-
Improving the outcomes: developing cancer therapeutics.Future Oncol. 2012 Jan;8(1):87-103. doi: 10.2217/fon.11.136. Future Oncol. 2012. PMID: 22149037 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
